Venrock Healthcare Capital Partners II, L.P. 13D and 13G filings for DBV Technologies S.A.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 6:08 pm Sale | 2025-12-31 | 13G | DBV TECHNOLOGIES S.A. ADR DBVT | Venrock Healthcare Capital Partners II, L.P. | 0 0.000% | -11,929,079 (Position Closed) | Filing |
| 2025-11-14 5:40 pm Sale | 2025-09-30 | 13G | DBV TECHNOLOGIES S.A. ADR DBVT | Venrock Healthcare Capital Partners II, L.P. | 11,929,079 8.200% | -2,357,474 (-16.50%) | Filing |
| 2025-08-14 6:01 pm Purchase | 2025-06-30 | 13G | DBV TECHNOLOGIES S.A. ADR DBVT | Venrock Healthcare Capital Partners II, L.P. | 14,286,553 9.800% | 13,321,087 (+1379.76%) | Filing |